Remedy Informatics Inc., a Salt Lake City-based company that provides software used in medical research, said it has received a $6 million capital investment from the Merck Global Health Innovation Fund.
The investment will give Merck a seat on Remedy’s board of director and paves the way for possible additional investments in the future, Gary Kennedy, Remedy’s founder and CEO, said in a statement announcing the investment.
 |
Join the Discussion |
 |
Post a Comment |
He said over the past year the company has experienced unprecedented demand for its research management systems. "This additional capital will fuel our growth here in the U.S. and our expansion into Europe and Latin America," he said.
In addition, Kennedy said the additional capital will allow Remedy to continue to invest in and develop its products so it can bolster its presence in the marketplace.
-
Utah gun sales, permits triple since Sandy Hook
Published May 18, 2013 01:01:09AM -
Weed: The new White Lightning
Published May 18, 2013 01:01:09AM -
Agnetha Faltskog reflects on ABBA, releases new solo album
Published May 18, 2013 01:01:09AM -
On the Job: Don’t kiss off the Q&A
Published May 18, 2013 01:01:08AM
Copyright 2013 The Salt Lake Tribune. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
